» Articles » PMID: 33418847

Deciphering the Importance of Glycosphingolipids on Cellular and Molecular Mechanisms Associated with Epithelial-to-Mesenchymal Transition in Cancer

Overview
Journal Biomolecules
Publisher MDPI
Date 2021 Jan 9
PMID 33418847
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Every living cell is covered with a dense and complex layer of glycans on the cell surface, which have important functions in the interaction between cells and their environment. Glycosphingolipids (GSLs) are glycans linked to lipid molecules that together with sphingolipids, sterols, and proteins form plasma membrane lipid rafts that contribute to membrane integrity and provide specific recognition sites. GSLs are subdivided into three major series (globo-, ganglio-, and neolacto-series) and are synthesized in a non-template driven process by enzymes localized in the ER and Golgi apparatus. Altered glycosylation of lipids are known to be involved in tumor development and metastasis. Metastasis is frequently linked with reversible epithelial-to-mesenchymal transition (EMT), a process involved in tumor progression, and the formation of new distant metastatic sites (mesenchymal-to-epithelial transition or MET). On a single cell basis, cancer cells lose their epithelial features to gain mesenchymal characteristics via mechanisms influenced by the composition of the GSLs on the cell surface. Here, we summarize the literature on GSLs in the context of reversible and cancer-associated EMT and discuss how the modification of GSLs at the cell surface may promote this process.

Citing Articles

Acetylated Globotetraose (Ac-Gb4) Suppresses Triple-Negative Breast Cancer Through FAK/AKT Signaling Pathway.

Lee Y, Sehar M, Botcha L, Chuang P Int J Mol Sci. 2025; 25(24.

PMID: 39769120 PMC: 11677054. DOI: 10.3390/ijms252413353.


TGF-β regulates the release of breast cancer cell-derived extracellular vesicles and the sorting of their protein cargo by downregulating RAB27B expression.

Li C, Enciso-Martinez A, Koning R, Shahsavari M, Ten Dijke P J Extracell Vesicles. 2024; 13(12):e70026.

PMID: 39723610 PMC: 11669950. DOI: 10.1002/jev2.70026.


Pathogenic mitochondrial DNA variants are associated with response to anti-VEGF therapy in ovarian cancer PDX models.

Boso D, Piga I, Trento C, Minuzzo S, Angi E, Iommarini L J Exp Clin Cancer Res. 2024; 43(1):325.

PMID: 39702370 PMC: 11657443. DOI: 10.1186/s13046-024-03239-w.


Human Gb3/CD77 synthase: a glycosyltransferase at the crossroads of immunohematology, toxicology, and cancer research.

Szymczak-Kulus K, Czerwinski M, Kaczmarek R Cell Mol Biol Lett. 2024; 29(1):137.

PMID: 39511480 PMC: 11546571. DOI: 10.1186/s11658-024-00658-7.


Glycosphingolipids in Cardiovascular Disease: Insights from Molecular Mechanisms and Heart Failure Models.

Huang S, Abutaleb K, Mishra S Biomolecules. 2024; 14(10).

PMID: 39456198 PMC: 11506000. DOI: 10.3390/biom14101265.


References
1.
Geyer P, Maak M, Nitsche U, Perl M, Novotny A, Slotta-Huspenina J . Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit. Mol Cancer Ther. 2016; 15(5):1008-17. DOI: 10.1158/1535-7163.MCT-15-0633. View

2.
Merrill Jr A . Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem Rev. 2011; 111(10):6387-422. PMC: 3191729. DOI: 10.1021/cr2002917. View

3.
Guan F, Schaffer L, Handa K, Hakomori S . Functional role of gangliotetraosylceramide in epithelial-to-mesenchymal transition process induced by hypoxia and by TGF-{beta}. FASEB J. 2010; 24(12):4889-903. PMC: 2992377. DOI: 10.1096/fj.10-162107. View

4.
Jacob F, Alam S, Konantz M, Liang C, Kohler R, Everest-Dass A . Transition of Mesenchymal and Epithelial Cancer Cells Depends on α1-4 Galactosyltransferase-Mediated Glycosphingolipids. Cancer Res. 2018; 78(11):2952-2965. DOI: 10.1158/0008-5472.CAN-17-2223. View

5.
Jin U, Chung T, Song K, Kwak C, Choi H, Ha K . Ganglioside GM3 is required for caffeic acid phenethyl ester-induced megakaryocytic differentiation of human chronic myelogenous leukemia K562 cells. Biochem Cell Biol. 2014; 92(4):243-9. DOI: 10.1139/bcb-2014-0015. View